ONEINFORTY SYMPOSIUM REGISTER TODAY!
Knowledge is Empowering:
Understanding the Jewish - Cancer Connection
Thursday, March 14, 2019
7:45 - 9:15 p.m.
385 Ward St.
Newton, MA 02459
Temple Emanuel, located in Newton, Massachusetts, will host this Oneinforty symposium to educate the community about Ashkenazi Jews' one-in-forty risk of inheriting a BRCA gene mutation. Having a BRCA gene mutation significantly increases one's risk of developing breast, ovarian, prostate and other cancers that, in many cases, can be prevented or detected early.
Panelists will discuss genetic counseling, the rationale for testing for BRCA gene mutations, managing cancer risk and resources available for those who carry BRCA gene mutations. You will also learn about the new BRCA Founder Outreach (BFOR) Study that offers no-cost screening for the three BRCA founder mutations through Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering, Cedars-Sinai Medical Center, Penn Medicine and the Basser Center for BRCA. Jewish individuals who have a BRCA gene mutation will also share their stories. Following presentations by each of the panelists listed below, there will be a Q&A session.
Founder & Executive Director, Oneinforty
BRCA-positive ovarian cancer thriver
Elizabeth Etkin-Kramer, MD, FACOG
Founder & Executive Director, Yodeah
Whitfield B. Growdon, MD
Massachusetts General Hospital
Randi D. Leigh, MD
Brigham and Women's Hospital
Marcia Lewin-Berlin, LICSW, ACHP-SW
Social worker in private practice
This symposium is free-of-charge and open to the general public. Kosher refreshments will be served.
Questions? Please contact Lauren Corduck at 617-823-3630 or firstname.lastname@example.org
Presented by Oneinforty, a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting BRCA gene mutations and provides the support individuals and families need to effectively manage their cancer risk.
Download a PDF of Oneinforty's spring 2019 symposium flyer